Australia - engleză - Department of Health (Therapeutic Goods Administration)

panpharma australia pty ltd - droperidol, quantity: 2.5 mg/ml - injection, solution - excipient ingredients: mannitol; tartaric acid; sodium hydroxide; nitrogen; water for injections - anaesthesia droperidol panpharma injection is indicated to produce tranquillisation and to reduce the incidence of nausea and vomiting in surgical and diagnostic procedures; for premedication, induction, and as an adjunct in the maintenance of general and regional anaesthesia; in neuroleptanalgesia in which droperidol panpharma injection is given concurrently with a narcotic analgesic, to aid in producing tranquillity and decreasing anxiety and pain.,psychiatry the management of severe agitation, hyperactivity, or aggressiveness in psychotic disorders, including schizophrenic reaction and the manic type of manic depressive illness, or in disturbed states, such as some types of acute brain syndrome and in nonpsychotic acute excitation states.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - droperidol, quantity: 2.5 mg/ml - injection, solution - excipient ingredients: tartaric acid; mannitol; water for injections - in anaesthesia - drolepton is indicated to produce tranquillisation and to reduce the incidence of nausea and vomiting in surgical and diagnostic procedures; for premedication, induction, and as an adjunct in the maintenance of general and regional anaesthesia; in neuroleptanalgesia in which droleptan is given concurrently with a narcotic analgesic, to aid in producing tranquillity and decreasing anxiety and pain. in psychiatry - the management of severe agitation, hyperactivity, or agressiveness in psychotic disorders, including schizophrenic reaction and the manic type of manic depressive illness, or in disturbed states, such as some types of acute brain syndrome and in nonpsychotic acute excitation states.

Regatul Unit - engleză - VMD (Veterinary Medicines Directorate)

elanco europe ltd - xylazine - solution for injection - neurological agent sedative - cats, cattle, dogs, horses

Australia - engleză - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - tramadol hydrochloride, quantity: 200 mg - tablet, modified release - excipient ingredients: colloidal anhydrous silica; magnesium stearate; hyprolose; calcium hydrogen phosphate dihydrate - indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long-term treatment. not indicated for use in chronic non-cancer pain other than in exceptional circumstances. not indicated as an as-needed (prn) analgesia.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - tramadol hydrochloride, quantity: 150 mg - tablet, modified release - excipient ingredients: hyprolose; magnesium stearate; colloidal anhydrous silica; calcium hydrogen phosphate dihydrate - indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long-term treatment. not indicated for use in chronic non-cancer pain other than in exceptional circumstances. not indicated as an as-needed (prn) analgesia.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - tramadol hydrochloride, quantity: 100 mg - tablet, modified release - excipient ingredients: magnesium stearate; colloidal anhydrous silica; hyprolose; calcium hydrogen phosphate dihydrate - indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long-term treatment. not indicated for use in chronic non-cancer pain other than in exceptional circumstances. not indicated as an as-needed (prn) analgesia.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - tramadol hydrochloride, quantity: 200 mg - tablet, modified release - excipient ingredients: calcium hydrogen phosphate dihydrate; hyprolose; colloidal anhydrous silica; magnesium stearate - indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long-term treatment. not indicated for use in chronic non-cancer pain other than in exceptional circumstances. not indicated as an as-needed (prn) analgesia.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - tramadol hydrochloride, quantity: 150 mg - tablet, modified release - excipient ingredients: colloidal anhydrous silica; magnesium stearate; hyprolose; calcium hydrogen phosphate dihydrate - indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long-term treatment. not indicated for use in chronic non-cancer pain other than in exceptional circumstances. not indicated as an as-needed (prn) analgesia.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - tramadol hydrochloride, quantity: 100 mg - tablet, modified release - excipient ingredients: hyprolose; colloidal anhydrous silica; calcium hydrogen phosphate dihydrate; magnesium stearate - indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long-term treatment. not indicated for use in chronic non-cancer pain other than in exceptional circumstances. not indicated as an as-needed (prn) analgesia.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - tramadol hydrochloride, quantity: 50 mg - tablet, modified release - excipient ingredients: lactose monohydrate; magnesium stearate; iron oxide yellow; hypromellose; microcrystalline cellulose; titanium dioxide; macrogol 6000; colloidal anhydrous silica; purified talc; propylene glycol - zydol sr is indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long term treatment. zydol sr is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. zydol sr is not indicated as an as-needed (prn) analgesia.